Achieve Life Sciences (ACHV) Other Accumulated Expenses (2013 - 2026)

Achieve Life Sciences' Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• Quarterly Other Accumulated Expenses rose 78.83% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 78.83% YoY) and the FY2025 annual result came in at $598000.0, up 4.36% from the prior year.
• Other Accumulated Expenses was $2.3 million for Q1 2026 at Achieve Life Sciences, up from $598000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.3 million in Q1 2026 and bottomed at $351000.0 in Q4 2023.
• A 5-year average of $881058.8 and a median of $693000.0 in 2023 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 207.11% — and 2024, when it retreated 17.95%.
• Achieve Life Sciences' Other Accumulated Expenses stood at $403000.0 in 2022, then dropped by 12.9% to $351000.0 in 2023, then jumped by 63.25% to $573000.0 in 2024, then increased by 4.36% to $598000.0 in 2025, then surged by 289.97% to $2.3 million in 2026.
• Business Quant data shows ACHV's Other Accumulated Expenses at $2.3 million in Q1 2026, $598000.0 in Q4 2025, and $1.8 million in Q3 2025.